Stay updated with breaking news from Coreyn fishman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Iterum Therapeutics plc (NASDAQ:ITRM) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) saw a large decline in short interest in April. As of April 30th, there was short interest totalling 76,400 shares, a decline of 26.5% from the April 15th total of 103,900 shares. Based on an average daily volume of 63,500 shares, the short-interest ratio is presently 1.2 days. […] ....
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) saw a large drop in short interest in March. As of March 15th, there was short interest totalling 154,400 shares, a drop of 15.5% from the February 28th total of 182,700 shares. Based on an average daily volume of 101,600 shares, the short-interest ratio is presently 1.5 days. […] ....
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 154,400 shares, a decrease of 15.5% from the February 28th total of 182,700 shares. Based on an average daily volume of 101,600 shares, the […] ....
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 154,400 shares, a drop of 15.5% from the February 28th total of 182,700 shares. Approximately 1.2% of the shares of the company are sold short. Based on […] ....